| US 7,493,171 B1 | ||
| Treatment of pathologic craving and aversion syndromes and eating disorders by electrical brain stimulation and/or drug infusion | ||
| Todd K Whitehurst, Santa Clarita, Calif. (US); James C Makous, Santa Clarita, Calif. (US); Rafael Carbunaru, Studio City, Calif. (US); and Kristen N Jaax, Saugus, Calif. (US) | ||
| Assigned to Boston Scientific Neuromodulation Corp., Valencia, Calif. (US) | ||
| Filed on May 27, 2005, as Appl. No. 11/140,152. | ||
| Application 11/140152 is a continuation in part of application No. 09/993086, filed on Nov. 06, 2001, granted, now 6,950,707. | ||
| Claims priority of provisional application 60/252625, filed on Nov. 21, 2000. | ||
| Int. Cl. A61N 1/00 (2006.01) | ||
| U.S. Cl. 607—58 [607/45; 128/898] | 15 Claims |
| 1. A method of treating a patient with an alcohol addiction, comprising:
implanting one or more system control units in the patient, wherein one or more of the system control units are connected
to and control one or more electrodes and/or drug delivery catheters that are implanted in the brain of the patient; and
delivering a stimulus configured to treat the alcohol addiction with one or more of the system control units via the one or
more electrodes and/or drug delivery catheters to at least one of an anterior insula and a dorsal putamen.
|